Sherry Bhalla

2.0k total citations
32 papers, 1.4k citations indexed

About

Sherry Bhalla is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Sherry Bhalla has authored 32 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Molecular Biology, 8 papers in Pulmonary and Respiratory Medicine and 8 papers in Oncology. Recurrent topics in Sherry Bhalla's work include vaccines and immunoinformatics approaches (6 papers), Multiple Myeloma Research and Treatments (5 papers) and Protein Degradation and Inhibitors (5 papers). Sherry Bhalla is often cited by papers focused on vaccines and immunoinformatics approaches (6 papers), Multiple Myeloma Research and Treatments (5 papers) and Protein Degradation and Inhibitors (5 papers). Sherry Bhalla collaborates with scholars based in India, United States and Germany. Sherry Bhalla's co-authors include Gajendra P. S. Raghava, Salman Sadullah Usmani, Kumardeep Chaudhary, Piyush Agrawal, Ankur Gautam, Sandeep Singh, Harpreet Kaur, Rajesh Kumar, Alessandro Laganà and Meenu Sharma and has published in prestigious journals such as Nucleic Acids Research, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Sherry Bhalla

28 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sherry Bhalla India 17 977 341 198 157 102 32 1.4k
Grish C. Varshney India 22 1.2k 1.2× 292 0.9× 311 1.6× 232 1.5× 70 0.7× 42 1.7k
Jagat Chauhan United Kingdom 20 1.2k 1.3× 90 0.3× 234 1.2× 155 1.0× 201 2.0× 31 1.5k
Thierry Christophe France 21 681 0.7× 158 0.5× 256 1.3× 362 2.3× 38 0.4× 32 1.4k
Huanyu Tao China 12 995 1.0× 71 0.2× 85 0.4× 128 0.8× 179 1.8× 21 1.5k
Kristen M. Varney United States 22 1.4k 1.4× 105 0.3× 130 0.7× 234 1.5× 144 1.4× 59 1.7k
Javier Delgado Spain 18 900 0.9× 130 0.4× 45 0.2× 80 0.5× 59 0.6× 33 1.3k
Bodil Basse Denmark 14 1.1k 1.2× 152 0.4× 115 0.6× 257 1.6× 26 0.3× 17 1.6k
Piyush Agrawal India 17 1.4k 1.5× 560 1.6× 84 0.4× 158 1.0× 207 2.0× 36 1.6k
Eydfinnur Olsen Denmark 10 1.0k 1.0× 165 0.5× 84 0.4× 266 1.7× 20 0.2× 10 1.4k

Countries citing papers authored by Sherry Bhalla

Since Specialization
Citations

This map shows the geographic impact of Sherry Bhalla's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sherry Bhalla with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sherry Bhalla more than expected).

Fields of papers citing papers by Sherry Bhalla

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sherry Bhalla. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sherry Bhalla. The network helps show where Sherry Bhalla may publish in the future.

Co-authorship network of co-authors of Sherry Bhalla

This figure shows the co-authorship network connecting the top 25 collaborators of Sherry Bhalla. A scholar is included among the top collaborators of Sherry Bhalla based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sherry Bhalla. Sherry Bhalla is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Singh, Jay, Sarita Kumari, Jayanth Kumar, et al.. (2025). Integrative Genetic and Transcriptomic Subtyping Improves Prognosis Prediction in B-Lineage Acute Lymphoblastic Leukemia. Laboratory Investigation. 105(9). 104201–104201.
2.
Restrepo, Paula, Sherry Bhalla, Yogita Ghodke‐Puranik, et al.. (2022). A Three-Gene Signature Predicts Response to Selinexor in Multiple Myeloma. JCO Precision Oncology. 6(6). e2200147–e2200147. 14 indexed citations
3.
Bhalla, Sherry & Alessandro Laganà. (2022). Artificial Intelligence for Precision Oncology. Advances in experimental medicine and biology. 1361. 249–268. 30 indexed citations
4.
Upadhyay, Ranjan, Jonathan Boiarsky, Judit Svensson‐Arvelund, et al.. (2021). A Critical Role for Fas-Mediated Off-Target Tumor Killing in T-cell Immunotherapy. Cancer Discovery. 11(3). 599–613. 125 indexed citations
5.
Restrepo, Paula, Sherry Bhalla, Adolfo Aleman, et al.. (2021). Transcriptomic Correlates of Response to Selinexor in Multiple Myeloma Reveal a Predictive Signature. Blood. 138(Supplement 1). 457–457. 1 indexed citations
6.
Chari, Ajai, Erika Florendo, Deepu Madduri, et al.. (2021). Optimal Supportive Care With Selinexor Improves Outcomes in Patients With Relapsed/Refractory Multiple Myeloma. Clinical Lymphoma Myeloma & Leukemia. 21(12). e975–e984. 5 indexed citations
7.
Chaudhary, Anita, Sherry Bhalla, Sumeet Patiyal, Gajendra P. S. Raghava, & Girish Sahni. (2021). FermFooDb: A database of bioactive peptides derived from fermented foods. Heliyon. 7(4). e06668–e06668. 57 indexed citations
8.
Dhall, Anjali, Sumeet Patiyal, Harpreet Kaur, et al.. (2020). Computing Skin Cutaneous Melanoma Outcome From the HLA-Alleles and Clinical Characteristics. Frontiers in Genetics. 11. 221–221. 26 indexed citations
9.
Bhalla, Sherry, Harpreet Kaur, Rishemjit Kaur, Suresh Sharma, & Gajendra P. S. Raghava. (2020). Expression based biomarkers and models to classify early and late-stage samples of Papillary Thyroid Carcinoma. PLoS ONE. 15(4). e0231629–e0231629. 12 indexed citations
10.
Kaur, Harpreet, Sherry Bhalla, & Gajendra P. S. Raghava. (2019). Classification of early and late stage liver hepatocellular carcinoma patients from their genomics and epigenomics profiles. PLoS ONE. 14(9). e0221476–e0221476. 37 indexed citations
11.
Bhalla, Sherry, Harpreet Kaur, Anjali Dhall, & Gajendra P. S. Raghava. (2019). Prediction and Analysis of Skin Cancer Progression using Genomics Profiles of Patients. Scientific Reports. 9(1). 15790–15790. 52 indexed citations
12.
Agrawal, Piyush, Sherry Bhalla, Kumardeep Chaudhary, et al.. (2018). In Silico Approach for Prediction of Antifungal Peptides. Frontiers in Microbiology. 9. 323–323. 129 indexed citations
13.
Kumar, Vinod, Piyush Agrawal, Rajesh Kumar, et al.. (2018). Prediction of Cell-Penetrating Potential of Modified Peptides Containing Natural and Chemically Modified Residues. Frontiers in Microbiology. 9. 725–725. 56 indexed citations
14.
Usmani, Salman Sadullah, Rajesh Kumar, Sherry Bhalla, Vinod Kumar, & Gajendra P. S. Raghava. (2018). In Silico Tools and Databases for Designing Peptide-Based Vaccine and Drugs. Advances in protein chemistry and structural biology. 112. 221–263. 48 indexed citations
15.
Bhalla, Sherry, Ruchi Verma, Harpreet Kaur, et al.. (2017). CancerPDF: A repository of cancer-associated peptidome found in human biofluids. Scientific Reports. 7(1). 1511–1511. 30 indexed citations
16.
Singh, Sandeep, Kumardeep Chaudhary, Sandeep Kumar Dhanda, et al.. (2015). SATPdb: a database of structurally annotated therapeutic peptides. Nucleic Acids Research. 44(D1). D1119–D1126. 169 indexed citations
17.
Agrawal, Piyush, Sherry Bhalla, Salman Sadullah Usmani, et al.. (2015). CPPsite 2.0: a repository of experimentally validated cell-penetrating peptides. Nucleic Acids Research. 44(D1). D1098–D1103. 259 indexed citations
18.
Bhati, Kaushal Kumar, Sipla Aggarwal, Shivani Sharma, et al.. (2014). Differential expression of structural genes for the late phase of phytic acid biosynthesis in developing seeds of wheat (Triticum aestivum L.). Plant Science. 224. 74–85. 70 indexed citations
19.
Anderson, Helén, H. Riska, Serena Knowles, et al.. (2005). Palliative chemotherapy of non-small cell lung cancer (NSCLC): Baseline data analysis of the ACTION observational study in 5 European countries. Journal of Clinical Oncology. 23(16_suppl). 7216–7216. 1 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Grish C. Varshney Breakdown of academic impact, for papers by Jagat Chauhan Breakdown of academic impact, for papers by Thierry Christophe Breakdown of academic impact, for papers by Huanyu Tao Breakdown of academic impact, for papers by Kristen M. Varney Breakdown of academic impact, for papers by Javier Delgado Breakdown of academic impact, for papers by Bodil Basse Breakdown of academic impact, for papers by Piyush Agrawal Breakdown of academic impact, for papers by Eydfinnur Olsen
Rankless by CCL
2026